Premium
The Indian healthtech sector may be facing a time of reckoning as investment dries up gradually. As the $6.5 billion sector grapples with a plethora of issues ranging from delayed profitability, stagnant scale to offline competition, investors now seek businesses that are relatively closer or have already turned the corner and ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
